Diagnostic value of multimodal ultrasound for breast cancer and prediction of sentinel lymph node metastases
View abstract on PubMed
Summary
This summary is machine-generated.A new Lasso regression model using multimodal ultrasound accurately predicts sentinel lymph node metastasis in breast cancer. This advancement aids in better prognosis and treatment planning for breast cancer patients.
Area Of Science
- Oncology
- Medical Imaging
Background
- Sentinel lymph node metastasis (SLNM) is crucial for breast cancer (BC) prognosis and treatment planning.
- Accurate SLNM prediction is essential for improving patient outcomes.
Purpose Of The Study
- To develop a Lasso regression model integrating multimodal ultrasound (US) techniques.
- To enhance the predictive accuracy of SLNM in breast cancer.
- To provide precise clinical treatment guidance.
Main Methods
- Utilized multimodal ultrasound techniques: standard US, shear wave elastography (SWE), and contrast-enhanced ultrasound (CEUS).
- Constructed a Lasso regression model incorporating these US modalities.
- Evaluated model performance in diagnosing benign/malignant nodules and SLNM.
Main Results
- The Lasso model achieved an AUC of 0.966 for diagnosing benign and malignant nodules.
- The model demonstrated an AUC of 0.832 for diagnosing SLNM.
- Significant differences were observed between benign and malignant groups across various clinical and imaging features.
Conclusions
- A validated Lasso regression model based on multimodal US effectively predicts SLNM in breast cancer.
- The developed model exhibits high diagnostic accuracy for SLNM prediction.

